Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study

Abstract Background Rapid diagnostic tests detecting microbial resistance are needed for limiting the duration of inappropriateness of empirical antimicrobial therapy (EAT) in intensive care unit patients, besides reducing the use of broad-spectrum antibiotics. We hypothesized that the betaLACTA® te...

Full description

Bibliographic Details
Main Authors:	Marc Garnier, Sacha Rozencwajg, Tài Pham, Sophie Vimont, Clarisse Blayau, Mehdi Hafiani, Jean-Pierre Fulgencio, Francis Bonnet, Jean-Luc Mainardi, Guillaume Arlet, Muriel Fartoukh, Salah Gallah, Christophe Quesnel
Format:	Article
Language:	English
Published:	BMC 2017-06-01
Series:	Critical Care
Subjects:	Antimicrobial agent administration Microbial susceptibility tests Beta-lactam resistance Extended-spectrum beta-lactamase Intensive care unit
Online Access:	http://link.springer.com/article/10.1186/s13054-017-1746-6

Similar Items

The Beta-Lactam Resistome Expressed by Aerobic and Anaerobic Bacteria Isolated from Human Feces of Healthy Donors
by: Rosalino Vázquez-López, et al.
Published: (2021-06-01)

SYN-007, an Orally Administered Beta-Lactamase Enzyme, Protects the Gut Microbiome from Oral Amoxicillin/Clavulanate without Adversely Affecting Antibiotic Systemic Absorption in Dogs
by: Sheila Connelly, et al.
Published: (2020-01-01)

Low dose oral beta-lactamase protects the gut microbiome from oral beta-lactam-mediated damage in dogs
by: Sheila Connelly, et al.
Published: (2019-11-01)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01)

A Case Series of Piperacillin-Tazobactam Induced Hypokalemia in a Tertiary Care Hospital in South India
by: Kunder SK, et al.
Published: (2016-01-01)

Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy
by: Trupti Bajpai, et al.
Published: (2014-01-01)

Dual β-Lactam Combinations Highly Active against <named-content content-type="genus-species">Mycobacterium abscessus</named-content> Complex <italic toggle="yes">In Vitro</italic>
by: R. Pandey, et al.
Published: (2019-02-01)

The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase
by: Krisztina M. Papp-Wallace, et al.
Published: (2023-05-01)

Identification of drivers of mycobacterial resistance to peptidoglycan synthesis inhibitors
by: Francisco Olivença, et al.
Published: (2022-09-01)

<italic toggle="yes">Klebsiella pneumoniae</italic> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
by: Melissa D. Barnes, et al.
Published: (2017-11-01)

<i>Klebsiella pneumoniae</i> Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio
by: Maria V. Golikova, et al.
Published: (2022-06-01)

Prevalence of TEM, SHV, and CTX-M Beta-Lactamase genes in the urinary isolates of a tertiary care hospital
by: Trupti Bajpai, et al.
Published: (2017-01-01)

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020
by: Denis Piérard, et al.
Published: (2023-11-01)

Molecular investigations of PenA-mediated beta-lactam resistance inBurkholderia pseudomallei
by: Drew A Rholl, et al.
Published: (2011-07-01)

Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>
by: Melissa D. Barnes, et al.
Published: (2018-12-01)

Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins
by: Varsha Gupta, et al.

Prevalence of extended-spectrum beta-lactamases, AmpC beta-lactamase, and metallo-beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii in an intensive care unit in a tertiary care hospital
by: Varun Goel, et al.
Published: (2013-01-01)

Extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniaei: A Multi-centric Study Across Karnataka
by: Sridhar PN Rao, et al.
Published: (2014-01-01)

Metallo-β-lactamase-production in meropenem-susceptible Pseudomonas aeruginosa isolates: risk for silent spread
by: Renata Cristina Picão, et al.
Published: (2012-09-01)

Prevalence of extended spectrum beta lactamase and AmpC beta lactamase producers among <i><i>Escherichia</i> coli</i> isolates in a tertiary care hospital in Jaipur
by: Sinha Parul, et al.
Published: (2008-07-01)

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance
by: Richard eWatkins, et al.
Published: (2013-12-01)

Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory
by: Carmella Russo, et al.
Published: (2023-12-01)

Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy
by: Nosheen Nasir, et al.
Published: (2019-09-01)

Evaluation of determination of 6-aminopenicillanic acid by p-dimethyl aminobenzaldehyde /
by: 408833 Shewale, Jaiprakash G., et al.

Functional Dynamics of Substrate Recognition in TEM Beta-Lactamase
by: Chris Avery, et al.
Published: (2022-05-01)

Investigation of Prevalence of Extended-Spectrum β-Lactamase PER Gene in Acinetobacter baumannii Isolated from Hospitalized Patients in Qom Province (Iran)
by: Hasan Vahidi Emami, et al.
Published: (2018-02-01)

Biochemistry of peptide antibiotics : recent advances in the biotechnology of beta-lactams and microbial bioactive peptides /
by: Kleinkauf, Horst, et al.
Published: (1990)

Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible <i>Escherichia coli</i>: A Missed Opportunity for De-Escalation of Therapy
by: Leah Carlisle, et al.
Published: (2018-12-01)

The biosynthesis of β-lactams
by: Goh, K, et al.
Published: (1993)

Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing <i>Klebsiella pneumoniae</i> and the Inoculum Effect
by: Elena N. Strukova, et al.
Published: (2023-12-01)

Genetic characterization of clinical <I>Klebsiella</I> isolates circulating in Novosibirsk
by: A. V. Bardasheva, et al.
Published: (2021-04-01)

Evaluation of Machine Learning and Rules-Based Approaches for Predicting Antimicrobial Resistance Profiles in Gram-negative Bacilli from Whole Genome Sequence Data
by: Mitchell Pesesky, et al.
Published: (2016-11-01)

Extended-spectrum beta-lactamase producers: Detection for the diagnostic laboratory
by: Rani Diana Sahni, et al.
Published: (2018-01-01)

Rapid identification of carbapenemases by CarbAcineto NP test and the rate of beta-lactamases among Acinetobacter baumannii from a teaching hospital
by: Morubagal Raghavendra Rao, et al.
Published: (2022-04-01)

A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment
by: Matthieu Grégoire, et al.
Published: (2021-01-01)

COMPARACIÓN DE LA PRUEBA TRIDIMENSIONAL CON PCR MÚLTIPLE, PARA DETECCIÓN DE CARBAPENEMASAS
by: María Isabel Múnera-Jaramillo
Published: (2018-09-01)

Extended-Spectrum Beta-Lactamases Producing <i>Enterobacteriaceae</i> in the USA Dairy Cattle Farms and Implications for Public Health
by: Benti Deresa Gelalcha, et al.
Published: (2022-09-01)

The current view on betalactam resistance in Staphylococcus aureus
by: Gostev V.V., et al.
Published: (2021-12-01)

Invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients
by: Isabelle Pierre, et al.
Published: (2014-12-01)

Molecular Epidemiology of blaCMY-1, blaCMY-2, blaFOX Genes in K. pneumoniae From Elderly Patients in Tehran, Iran
by: Ali Badamchi, et al.
Published: (2021-09-01)